WASHINGTON - Responding to the imminent threat to public health and safety, the U.S. Drug Enforcement (DEA) has placed U-47700 into Schedule I of the Controlled Substances Act, effective on November 14th. Emergency scheduling of dangerous drugs such as U-47700 on a temporary basis is one of the most significant...

OCT 28 - WASHINGTON, D.C. - Six years after the U.S. Drug Enforcement (DEA) launched its National Prescription Drug Take Back Day, Americans continue to turn out in large numbers to rid their homes of unused medications, including controlled prescription (CPDs) such as painkillers, tranquilizers, and stimulants. On October 22...

WASHINGTON - DEA reprises this weekend one of its most popular community programs: National Prescription Drug Take Back Day. On Saturday October 22 between 10 a.m. and 2 p.m., the public can dispose of their unused, unwanted prescription medications at one of 4,700 collection sites nationwide, operated by 3,800 local...

WASHINGTON - The United States Drug Enforcement (DEA) this week kicks off its annual Red Ribbon Campaign, the nation’s largest drug prevention effort. The National Red Ribbon Campaign began after drug traffickers in Mexico tortured and brutally murdered Special Agent Enrique “Kiki” Camarena in March 1985. Officially, Red Ribbon Week...

WASHINGTON - The United States Drug Enforcement (DEA) has reduced the amount of almost every Schedule II opiate and opioid medication that may be manufactured in the United States in 2017 by 25 percent or more, according to a being published in the Federal Register tomorrow and available for public...

WASHINGTON - In an effort to prevent drug use while educating youth, the National Family (NFP), invites families and schools across America to participate in its 6th Annual National Red Ribbon Week Photo Contest. The contest, which is co-sponsored by the Drug Enforcement (DEA), will be held in conjunction with...

WASHINGTON - This week the heads of the national drug-control agencies for the United States and the People’s Republic of China, Drug Enforcement (DEA) Acting Administrator Chuck Rosenberg and Director (DG) Hu Minglang from the Narcotics Control (NCB) of the Ministry of Public Security, met at DEA Headquarters in Arlington...

WASHINGTON - DEA has issued a public warning to the public and law enforcement nationwide about the health and safety risks of carfentanil. Carfentanil is a synthetic opioid that is 10,000 times more potent than morphine and 100 times more potent than fentanyl, which itself is 50 times more potent...

WASHINGTON - The Drug Enforcement (DEA) today announced its intention to place the active materials in the kratom plant into Schedule I of the Controlled Substances Act in order to avoid an imminent hazard to public safety. Mitragynine and 7-hydroxymitragynine are found in kratom, which is a tropical tree indigenous...

WASHINGTON - The Drug Enforcement (DEA) announced several marijuana- related actions, including actions regarding scientific research and scheduling of marijuana, as well as principles on the cultivation of industrial hemp under the Agricultural Act of 2014. DEA Publishes Responses to Two Pending Petitions to Reschedule Marijuana - DEA has denied...